1.
Antibodies against carbamylated proteins: prevalence and associated disease characteristics in Belgian patients with rheumatoid arthritis or other rheumatic diseases.
2.
3.
4.
5.
6.
Antibodies against carbamylated proteins: prevalence and associated disease characteristics in Belgian patients with rheumatoid arthritis or other rheumatic diseases
Het belgian Cap48 ra Cohort : het belang van vroege remissie
SAT0076 EARLY REMISSION IS ESSENTIAL TO PREDICT LONGTERM REMISSION. CLINICAL RESULTS OF THE BELGIAN CAP48 RA COHORT
La Belgian CAP48 RA Cohort: l’importance de la rémission précoce